Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
Abstract
On March 16, 2026, the Drug Enforcement Administration published a temporary order placing 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA published this temporary order that included an invalid chemical name for bromazolam. This document corrects that error, adding the valid chemical name for bromazolam.
Federal Register Source
This document is published by the Office of the Federal Register, National Archives and Records Administration. Access the full regulatory text, preamble, and docket comments below.
View Full Text on FederalRegister.gov →Opens in new tab · federalregister.gov
Frequently Asked Questions
What is the 2026-12653 Federal Register document?
Is document 2026-12653 an economically significant rule?
Other Rules from DOJ
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainRegWatch is rendered from curated state legislative and Federal Register source data, no number is typed in by an editor. Figures on this page come from the curated five-category archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Tracker scores and rule counts are curated records in five tracked categories - not enforcement strength, legal advice, a complete inventory of US law, or a live bill-status feed.